Warning: Undefined variable $page_cluster_id in /home3/thegood9/public_html/website_70aad9ea/header.php on line 29



Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Tag Directory / DIABETES     showing 1–1 of 1   RSS

for: Saturday, March 28, 2026



FDA approves 1st weekly basal insulin for Type 2 diabetes

Ella Jeffries / beckershospitalreview - The FDA has approved Novo Nordisk’s Awiqli (insulin icodec-abae), making it the first once-weekly basal insulin available in the U.S. for adults with Type 2 diabetes. Awiqli is indicated as an adjunct to diet and exercise and is intended to reduce injecti…

AI Summary: The FDA approved the first once‑weekly basal insulin for adults with Type 2 diabetes, providing an alternative to daily injections and aiming to improve adherence and glycemic control. Regulators based the decision on trials showing comparable efficacy and safety to daily basal insulins, potentially reshaping diabetes management.

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda #clinicaltrials #diabetes

Mutation map reveals how amylin mutations influence type 2 diabetes

2 months / medicalxpress

FDA approves 1st weekly basal insulin for Type 2 diabetes

2 months / beckershospitalreview / Ella Jeffries

FDA approves Novo Nordisk's once-weekly insulin

2 months / endpoints / Anna Brown

Back to Top / Saturday, March 28, 2026, 12:23 am / permalink 21436 / 3 stories in 2 months /

Back to Top


DIABETES Heatmap

90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.


StackHealth RSS

You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Cancer Screening, Vitamin D, Supply Chain, Supplements and look for the RSS link.

Back to Top
↑

NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.